Use of tetrahydropyridines in the treatment of central nervous system disorders

US7851487B2 · kind B2 · utility

Assignees

• The Research Foundation of the State University of New York · US
• Chakra Biotech Pte Ltd. · SG

Inventors

• Huw M. L. Davies · East Amherst, US
• Anil Kumar Ratty · Singapore, SG

Key dates

• Filing date: Mar 12, 2007
• Grant date: Dec 14, 2010
• Expiry date: Oct 20, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2601/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are methods for alleviating symptoms of neuropsychiatric disorders using tetrahydropyridine derivatives bearing aromatic substituents. The method comprises administering to an individual a tetrahydropyridine derivative bearing aromatic substituents in an amount effective to alleviate symptoms of the neuropsychiatric disorder.